NL-OMON40038已完成2 期
Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction: the EXAMI trial - EXAMI
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 125
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •-First myocardial infarction
- •-ST elevation of at least 0,1mV in at least 2 contiguous leads
- •- > 18 years of age
- •- Delay between onset of sustained chestpain and PCI < 6 hours
排除标准
- •-Diabetes type I or II
- •-Heartfailure (Kilip III or IV)
- •-No definite Culprit
- •-More than one occluded vessel, or a more than 70% stenosis by visual assessment in a non-culprit vessel.
- •-No recanalisation achieved of the occluded coronary artery
- •-Decreased renal function eGFR < 30ml/min
- •-Any contraindication for MRI
- •- TIMI 2 or 3 flow in culprit lesion at presentation
研究者
相似试验
进行中（未招募）
不适用
Effect of additional treatment with exenatide in patients with an acute myocardial infarction: the EXAMI trial)EUCTR2009-014272-21-NLVU University Medical Center40
进行中（未招募）
1 期
Exenatide Treatment in Parkinson's DiseaseParkinson's diseaseEUCTR2019-000732-26-SEStockholm Health Care Services60
招募中
不适用
Comparison of efficacy and safety of exenatide extended-release and dulaglutide in type 2 diabetes mellitus patients who are insufficiently controlled with oral antidiabetic agentsType 2 diabetes mellitusJPRN-UMIN000019096Haga Diabetes Clinic75
进行中（未招募）
不适用
A Study to Assess the Effect of Exenatide Treatment on Mean 24-hour Heart Rate in Patients with Type 2 Diabetes - GWCDEUCTR2007-002691-33-NLEli Lilly and Company Ltd50
已完成
不适用
Effects of exenatide extended-release in patients with type 2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000018740Tokyo Women's Medical University100